pfizer covid - Search News

News

Pfizer Raises Profit View

Yahoo Finance · 33m

Pfizer raises 2025 profit forecast as cost-cutting program gains traction

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting higher-than-expected second-quarter earnings on Tuesday. CEO Albert Bourla also said the company has been in active discussions with members of the U.

The Wall Street Journal on MSN · 2h

Pfizer Raises Profit Outlook as Uncertainty Lingers Over Tariffs, Drug Prices

Chief Executive Albert Bourla told analysts he is hopeful about finding a solution in response to President Trump’s demands.

Bloomberg on MSN · 2h

Pfizer Lifts Profit View as Cuts Offset Flat Sales Outlook

Pfizer Inc. raised its profit forecast for the year, with the drugmaker’s ongoing cost cuts helping to make up for a lack of expected sales growth.The company’s stock rose as much as 4.9% as markets opened in New York Tuesday as investors look for good news after a decline in demand for the company’s Covid products forced the drugmaker to reshape its business.

Pfizer, Q2 and PFE

Pfizer beats in Q2 earnings, reaffirms 2025 outlook

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 billion in revenues. The company reported revenues of $14.7 billion, compared to Wall Street expectations of $13.5 billion, and earnings per share of $0.78, versus estimates of $0.58 per share.

Zacks.com on MSN · 5h

Pfizer (PFE) Surpasses Q2 Earnings and Revenue Estimates

Pfizer (PFE) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.58 per share. This compares to earnings of $0.6 per share a year ago. These figures are adjusted for non-recurring items.

Seeking Alpha on MSN · 7h

Earnings Snapshot: Pfizer (PFE) tops Q2 results, raises FY2025 EPS outlook

Pfizer: Lack Of Enthusiasm Shouldn't Surprise You Pfizer's Comeback Is Underway Pfizer Non-GAAP EPS of $0.78 beats by $0.21, revenue of $14.65B beats by $1.12B, raises FY25 guidance Pfizer’s strong EP

1h

Pfizer shares rise 3% after upping profit forecast for 2025

Pfizer bucked the trend of a tepid big pharma Q2 window, raising its full-year profit forecast on the back of strong sales ...

5h

Pfizer stock pops as big pharma giant delivers post-COVID comeback

Pfizer stock rises after a strong Q2, boosted by cost savings, pipeline progress, and an upgraded 2025 profit outlook.

4h

Buy Pfizer Stock At $24?

Investor sentiment has been adversely affected by worries regarding the company’s drug pipeline. Nonetheless, we believe PFE ...

Free Malaysia Today on MSN3h

Pfizer profits boosted by Covid-19 products, lower expenses

Pfizer reported a jump in second quarter profits Tuesday behind higher sales of Covid 19 products and some other ...

MedPage Today on MSN21h

Did FDA Pick the Wrong COVID Vaccine Strain Last Season?

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...

4don MSN

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results